The present study provides independent evidence that miR-34a regulates the IL-6R/STAT3 pathway in ovarian cancer by demonstrating that IL-6R reexpression is able to mitigate the effects of miR-34a mimetic oligos (Supplementary Figure 2A). Here, STAT3 is linked to ovarian carcinoma.